ClinicalTrials.gg
CompletedNCT06720935COILSEALUpdated Dec 6, 2024

Use of Coils During Percutaneous Coronary Intervention

An observational study in Percutaneous Coronary Intervention (PCI) and Coronary Artery Disease, sponsored by San Luigi Gonzaga Hospital. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by San Luigi Gonzaga Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
143
Sex
All
01

Study summary

Use of coils during percutaneous coronary interventions (PCI) is sometimes life-saving and useful althought currently off-label and with unknown clinical outcomes. The study aims to report and compare in-hospital and long-term outcomes of patients undergoing coils implantation for treating coronary perforation or closing coronary aneurysms/fistulas.

Read the detailed description

Background. Use of coils during percutaneous coronary interventions (PCI) is sometimes life-saving and useful althought currently off-label and with unknown clinical outcomes Objectives. To report and compare in-hospital and long-term outcomes of patients undergoing coils implantation for treating coronary perforation or closing coronary aneurysms/fistulas.

Methods. Among 245.652 PCIs performed in 17 high-volume European centers, patients treated with coils will be identified.

The primary outcome was technical success, defined as the successful sealing coronary perforation or aneurysm/fistulas and procedural success defined as technical success without in-hospital Major Cardiovascular Events (MACe). Long-term MACE and mortality were also reported

02

Conditions studied

  • Percutaneous Coronary Intervention (PCI)
  • Coronary Artery Disease

Keywords

  • Coils
  • Coronary Artery Perforation
  • Coronary Fistulas
  • Coronary aneurysm
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's enrollment of 143 is below the median of 320 across 1,687 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

San Luigi Gonzaga Hospital is the lead sponsor of 20 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with coronary artery perforation or coronary fistula/aneurysm treated with coils embolization during percutaneous coronary intervention

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with coronary artery perforation or coronary artery fistula/aneurysm suitable treating with coils embolization

Exclusion criteria

Exclusion Criteria:

  • Patients without coronary artery disease suitable of coils treatment
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
143 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients undergoing to percutaneous coronary intervention with coils

    The study involves patients undergoing coils embolization for treating coronary artery perforation or coronary fistulas/aneurysm during percutaneous coronary intervention

06

What researchers measure

Primary outcomes

  1. Rate of Technical Success

    Rate of technical success is defined as effective sealing of coronary perforation or coronary fistulas/aneurysm after coils embolization

    Time frame: intraprocedural

Secondary outcomes

  1. Rate of Procedural success

    Rate of technical success without In Hospital Major Cardiovascular Events including death, target vessel myocardial infarction and re-PCI or CABG

    Time frame: Intraprocedural

07

Study locations

1 site
  • San Luigi Gonzaga Hospital
    Orbassano, Turin 10098, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in Sep 2024, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2024
First posted
Dec 6, 2024
StartActual
Jan 1, 2024
Primary completionActual
Sep 1, 2024
CompletionActual
Sep 28, 2024
Last update
Dec 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06720935
Lead sponsor
San Luigi Gonzaga Hospital
Responsible party
Enrico Cerrato (Interventional Cardiologist, San Luigi Gonzaga Hospital) — Principal investigator
First posted
Dec 6, 2024
Start date
Jan 1, 2024
Primary completion
Sep 1, 2024
Completion
Sep 28, 2024
Last update
Dec 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion